GenovaTSE:9341 -1.18%77 Operating Margin % is 6.63% as of Mar. 2026, which is 69% below its 10-year median of 21.58. GuruFocus rates TSE:9341 with a GF Score™ of 77/100 and a GF Value™ of 円1,926.20 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Genova ranks worse than 50.12% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Genova's Operating Income for the
six
months ended in Mar. 2026 was 円437 Mil. Genova's Revenue for the
six
months ended in Mar. 2026 was 円6,591 Mil. Therefore, Genova's Operating Margin % for the quarter that ended in Mar. 2026 was 6.63%.
Warning Sign:
Genova Inc operating margin has been in a 5-year decline. The average rate of decline per year is -23.4%.
The historical rank and industry rank for Genova's Operating Margin % or its related term are showing as below:
TSE:9341'
s Operating Margin % Range Over the Past 10 Years
Min: 3.46 Med: 21.58 Max: 26.62
Current: 3.46
TSE:9341's Operating Margin % is ranked worse than 50.12% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs TSE:9341: 3.46
Genova's 5-Year Average Operating Margin % Growth Rate was -23.40% per year.
Genova's Operating Income for the
six
months ended in Mar. 2026 was 円437 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was 円400 Mil.
Genova (TSE:9341) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Genova Operating Margin % Related Terms
Genova Operating Margin % Historical Data
* Premium members only.
The historical data trend for Genova's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9341 vs ABT, SYK, MDT: Operating Margin % Comparison
For the Medical Devices subindustry, Genova's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genova Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genova's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Genova's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Genova's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genova (TSE:9341) has a Operating Margin % of 6.63% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Genova and its competitors. This is 69% below median its historical median of 21.58. Over the past decade, Genova's Operating Margin % has ranged from 3.46 to 26.62. According to the industry distribution chart, Genova ranks #409 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is Genova's Operating Margin % too high?
Genova's current Operating Margin % of 6.63% is 69% below median its 10-year median of 21.58. Over the past 10 years, this metric has ranged from a low of 3.46 to a high of 26.62. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Genova's value of 6.63% is 91.3% above this industry median. Based on the distribution chart, Genova ranks #409 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Genova has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genova's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genova ranks #409 out of 816 companies for Operating Margin %. This places Genova in the lower half of its industry. The industry median Operating Margin % is 3.47. Genova's value of 6.63% is 91.3% above this benchmark. Historically, Genova's own Operating Margin % has ranged from 3.46 to 26.62 over the past decade. While the company's 10-year median is 21.58 vs. the industry median of 3.47, Genova has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genova's current Operating Margin % of 6.63% is 91.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Genova and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genova's current Operating Margin % is 6.63%, which is 69% below median its own 10-year median of 21.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genova stock overvalued right now?
Based on GuruFocus' analysis, Genova (TSE:9341) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,926.20, compared to a current price of 円585.00 — trading 69.6% below its estimated fair value. The current Operating Margin % is 6.63%, which is 69% below median its 10-year median of 21.58 and 91.3% above the Medical Devices & Instruments industry median of 3.47. Genova's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Genova (TSE:9341), the current Operating Margin % is 6.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genova (TSE:9341) Overvalued in 2026?
Based on GuruFocus' analysis, Genova stock appears to be undervalued.
The current stock price of 円585.00 is trading 69.6% below its estimated GF Value™ of 円1,926.20.
GuruFocus considers Genova to be Possible Value Trap.
Key valuation signals for TSE:9341:
Operating Margin %: 6.63% (69% below median its 10-year median of 21.58)
GF Value™: 円1,926.20 vs. price of 円585.00 (69.6% below fair value)
Industry Position: 91.3% above the Medical Devices & Instruments median (#409 of 816)
No single metric tells the full story. See the TSE:9341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genova Inc manages operations of the medical information site and sales of automatic reception and payment machines for clinics. The group operates in two reportable segments: Medical Platform Business and the Smart Clinic Project. The majority of its revenue is generated from the Medical Platform Business, which operates an online media site (Medical Dock) that provides preventive information and health knowledge to users (patients) on diseases and symptoms. In addition, it also supports users in finding a family doctor that suits them. The Smart Clinic Business develops and provides services that improve the convenience and efficiency of non-medical procedures at medical institutions.
77GF Score
Get the complete analysis for TSE:9341
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9341 has been successfully added to your 
